Insider · CIK 0001379344

Fischer Laurent

Reports to the SEC for 8 companies · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001379344

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-22	LYCALycia Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2026-09-11	ATAIAtaiBeckley Inc. · Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−206K sh	—	—	0
2026-09-11	ATAIAtaiBeckley Inc. · Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−103K sh	—	—	0
2026-09-11	ATAIAtaiBeckley Inc. · Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−122K sh	—	—	0
2026-08-11	LYCALycia Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.3K sh	—	—	13,307
2026-06-15	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,772 sh	—	—	3,772
2026-06-15	MIRMMirum Pharmaceuticals, Inc. · Deferred Stock UnitsA Award	Director	AAward	+1,980 sh	—	—	1,980
2026-06-04	ATAIAtaiBeckley Inc. · Stock OptionA Award	Director	AAward	+122K sh	—	—	121,968
2026-05-29	MIRMMirum Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,977 sh	—	—	10,727
2026-05-29	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,977 sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.M Exercise/Conversion	Director, CEO, PRESIDENT AND DIRECTOR	MExercise/Conversion	+150K sh	$4.20	+$630K	351,513
2025-12-09	Adverum Biotechnologies, Inc.U Disposition from Tender	Director, CEO, PRESIDENT AND DIRECTOR	UDisposition from Tender	−352K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.U Disposition from Tender	Director, CEO, PRESIDENT AND DIRECTOR	UDisposition from Tender	−25K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.A Award	Director, CEO, PRESIDENT AND DIRECTOR	AAward	+500K sh	—	—	522,666
2025-12-09	Adverum Biotechnologies, Inc.U Disposition from Tender	Director, CEO, PRESIDENT AND DIRECTOR	UDisposition from Tender	−523K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−93K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−200K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, CEO, PRESIDENT AND DIRECTOR	MExercise/Conversion	−150K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−120K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−68K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−45.5K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−63K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−31.5K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−58.5K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−67.5K sh	—	—	0
2025-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−110K sh	—	—	0
2025-12-08	Adverum Biotechnologies, Inc.P Purchase	Director, CEO, PRESIDENT AND DIRECTOR	PPurchase	+118K sh	$4.31	+$507K	201,513
2025-12-05	Adverum Biotechnologies, Inc.P Purchase	Director, CEO, PRESIDENT AND DIRECTOR	PPurchase	+11.1K sh	$4.24	+$47K	83,899
2025-06-26	ATAIAtai Beckley N.V. · Stock OptionA Award	Director	AAward	+103K sh	—	—	103,000
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−120K sh	—	—	0
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director, CEO, PRESIDENT AND DIRECTOR	AAward	+120K sh	—	—	120,000
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−68K sh	—	—	0
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director, CEO, PRESIDENT AND DIRECTOR	AAward	+68K sh	—	—	68,000
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−45.5K sh	—	—	0
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director, CEO, PRESIDENT AND DIRECTOR	AAward	+45.5K sh	—	—	45,499
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−63K sh	—	—	0
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director, CEO, PRESIDENT AND DIRECTOR	AAward	+63K sh	—	—	63,000
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−31.5K sh	—	—	0
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director, CEO, PRESIDENT AND DIRECTOR	AAward	+31.5K sh	—	—	31,500
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−58.5K sh	—	—	0
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director, CEO, PRESIDENT AND DIRECTOR	AAward	+58.5K sh	—	—	58,497
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−67.5K sh	—	—	0
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director, CEO, PRESIDENT AND DIRECTOR	AAward	+67.5K sh	—	—	67,502
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, CEO, PRESIDENT AND DIRECTOR	DDisposition to Issuer	−110K sh	—	—	0
2025-06-17	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director, CEO, PRESIDENT AND DIRECTOR	AAward	+110K sh	—	—	110,420
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+6,268 sh	—	—	6,268
2025-05-29	MIRMMirum Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+3,977 sh	—	—	3,977
2025-05-15	Adverum Biotechnologies, Inc.S Sale	Director, CEO, PRESIDENT AND DIRECTOR	SSale	−9,126 sh	$2.00	−$18.3K	87,488
2025-02-25	Adverum Biotechnologies, Inc.A Award	Director, CEO, PRESIDENT AND DIRECTOR	AAward	+25K sh	—	—	96,614
2025-02-25	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director, CEO, PRESIDENT AND DIRECTOR	AAward	+150K sh	—	—	150,000

Recent filings

Accepted (ET)
Oct 264
Fischer Laurent0001379344-26-000011
SEC(opens sec.gov)
Sep 114
Fischer Laurent0001140361-26-036384
SEC(opens sec.gov)
Jun 174
Fischer Laurent0001379344-26-000005
SEC(opens sec.gov)
Jun 84
Fischer Laurent0001140361-26-024525
SEC(opens sec.gov)
Jun 24
Fischer Laurent0001379344-26-000003
SEC(opens sec.gov)
Dec 104
Fischer Laurent0001379344-25-000006
SEC(opens sec.gov)

Companies

Address

C/O LYCIA THERAPEUTICS, INC. 400 EAST JAMIE COURT, SUITE 200

SOUTH SAN FRANCISCO, CA, 94080